Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity. (2014)

First Author: Schmid D
Attributed to:  Confidence in Concept 2012 - Queen's University Belfast funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/cddis.2014.413

PubMed Identifier: 25299779

Publication URI: http://europepmc.org/abstract/MED/25299779

Type: Journal Article/Review

Volume: 5

Parent Publication: Cell death & disease

Issue: 10